Journal article icon

Journal article

Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups

Abstract:

Background: COVID-19 vaccines approved in the UK are highly effective in general population cohorts, however, data on effectiveness amongst individuals with clinical conditions that place them at increased risk of severe disease are limited.

Methods: We used GP electronic health record data, sentinel virology swabbing and antibody testing within a cohort of 712 general practices across England to estimate vaccine antibody response and vaccine effec...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1016/j.jinf.2021.12.044

Authors


More by this author
Role:
Author
ORCID:
0000-0001-5833-1863
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
ORCID:
0000-0002-2520-526X
More by this author
Role:
Author
ORCID:
0000-0002-4792-8995
Expand authors...
Publisher:
Elsevier Publisher's website
Journal:
Journal of Infection Journal website
Volume:
84
Issue:
5
Pages:
675-683
Publication date:
2022-01-02
Acceptance date:
2021-12-29
DOI:
EISSN:
1532-2742
ISSN:
0163-4453
Pmid:
34990709
Language:
English
Keywords:
Pubs id:
1230305
Local pid:
pubs:1230305
Deposit date:
2022-07-01

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP